J&J Gives Anti-TB Drug To Group For Access In 130 Developing Nations
This article was originally published in PharmAsia News
Executive Summary
Johnson & Johnson said it would join other makers in contributing one of his drugs to the Stop TB Partnership of pharmaceutical companies to make key drugs accessible in 130 developing countries.